Your browser doesn't support javascript.
loading
Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
Winder, T; Giamas, G; Wilson, P M; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, H-J.
Afiliação
  • Winder T; Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.
  • Giamas G; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • Wilson PM; 1] Department of Pathology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA [2] Department of Biochemistry and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Ang
  • Zhang W; Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.
  • Yang D; Department of Preventive Medicine and Molecular Biology University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.
  • Bohanes P; Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.
  • Ning Y; Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.
  • Gerger A; Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.
  • Stebbing J; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • Lenz HJ; 1] Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA [2] Department of Preventive Medicine and Molecular Biology University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medici
Pharmacogenomics J ; 14(1): 28-34, 2014 Feb.
Article em En | MEDLINE | ID: mdl-23459444
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Receptores de Estrogênio / Receptor IGF Tipo 1 / Moduladores Seletivos de Receptor Estrogênico / Polimorfismo de Nucleotídeo Único Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Receptores de Estrogênio / Receptor IGF Tipo 1 / Moduladores Seletivos de Receptor Estrogênico / Polimorfismo de Nucleotídeo Único Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos